The science and the foundational funding leading to the current technologies in FSHD clinical trials.
Update: 2025-03-15
Description
"The most valuable commodity I know of is information." Today we discuss current clinical trials in FSHD and the foundational science behind the technology. While NIH has funded much of the foundational science that todays therapeutic approaches are built upon, it is the private individual and foundation support from those with vested interests in a rare disease that drive industry investment that gets the therapies over the line and into the clinic and ultimately to patients.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
